Navigation Links
Pro Hockey Player Fernando Pisani Looks to Shoot and Score Against Ulcerative Colitis
Date:3/2/2009

ef="http://www.crohnsinthezone.com/" target="_new">www.CrohnsintheZone.com), during the 2008 football season in partnership with professional quarterback, David Garrard. Garrard's efforts on the field resulted in a donation of $170,000 to the CCFA. The funds raised from In the Zone for Crohn's will help support continued Crohn's disease research and disease awareness programs.

"We look forward to continuing our partnership with Centocor Ortho Biotech and collaborating with Fernando Pisani on the In the Zone for UC program," said Richard Geswell, President of the Crohn's & Colitis Foundation of America. "We are confident that Fernando's success on the ice and in his everyday life will help inspire people living with inflammatory bowel diseases to join the fight in raising awareness and funds for these debilitating and often misunderstood diseases."

About Fernando Pisani

Fernando Pisani first began experiencing the painful symptoms of UC prior to the start of the 2007-08 season. Pisani experienced significant weight loss, fatigue and found it extremely difficult to keep up with the demands of playing professional hockey. The disease eventually caused Fernando to be sidelined for the first 26 games of the season and his return to his team was questionable. Pisani worked closely with his doctor to develop an effective treatment plan that controlled his symptoms and allowed him to return to the ice. In December 2007, Fernando returned to the ice and played the remainder of the season scoring 13 goals and adding nine assists.

About Ulcerative Colitis (UC)

UC, a chronic inflammatory bowel disease affecting nearly 500,000 people in the U.S., is marked by the inflammation and ulceration of the colonic mucosa, or innermost lining, which may lead to bloody stools, severe diarrhea and frequent abdominal pain. Tiny open sores, or ulcers, form on t
'/>"/>

SOURCE Centocor Ortho Biotech Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Ferring Pharmaceuticals Announces EUFLEXXA(TM) as Title Sponsor of the National Senior Games Hockey Championships and the GeezerJock of the Year Award
2. SURGEX(TM) Becomes the Official Sports Nutrition Drink of Former NBA Player Dee Brown and his Edge Basketball Training Facility
3. diaDexus, Inc. and Living Heart Foundation Offer the PLAC(R) Test to Detect Hidden Risk for Heart Attack and Stroke in Retired NFL Players
4. Gilead to Topple GSK as the Top Player in the Anti-Infectives Drug Market in 2014
5. Derma Sciences Expands Direct Sales Force for Advanced Wound Care, Looks to Double Again in 2008
6. DrScore.com Partners With Vivacare For Patient Education And Feedback
7. Researchers underscore limitations of genetic ancestry tests
8. Move to AMITIZA Advertising Campaign Underscores the Power of Not Letting Chronic Constipation Slow People Down
9. SDCRM Receives Highest Score in Three of Four Categories from CIRM on Part I of Major Facilities Grant Application
10. Genomic Health Announces Expansion of Oncotype DX(R) Breast Cancer Test to Include Quantitative Estrogen Receptor (ER) and Progesterone Receptor (PR) Scores
11. Major Independent Study Underscores Utility of deCODE MI(TM) for Better Predicting Risk of Heart Attack, Informing Statin Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... NEW YORK , Dec. 23, 2014 ... pilot study of mazindol in children with attention deficit/hyperactivity ... in December 2014 . The paper, ... with attention deficit/hyperactivity disorder" ( Konofal et al, ... 1;8:2321-2332. eCollection 2014 ) shows that mazindol might ...
(Date:12/22/2014)... 2014  Alternative Energy & Environmental Solutions, Inc., ... a letter of intent to acquire BioTechPharma Corporation, ... a nanotechnology-based development platform used to create drug ... on-site collection and testing to identify infectious disease, ... an immediate, non-invasive and cost-effective manner. ...
(Date:12/22/2014)... 22, 2014 ITRA Global, one of ... of commercial real estate, has further expanded its global ... Perth and Brisbane, Western Australia, reports Mylinda Vick, CCIM, ... ITRA Global / ACORPP (Australian Corporate Property and ... company providing property services to a wide range of ...
(Date:12/19/2014)... BioPlus Specialty Pharmacy (BioPlus), one of ... Nick Maroulis, Pharm.D. to the newly created position of ... this position, Dr. Maroulis will continue to manage the ... our multi-site pharmacies as the company expands. Dr. Maroulis ... time he has served in many different capacities in ...
Breaking Biology Technology:Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 2Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 3ALNE Announces Intention To Acquire BioTechPharma 2ITRA Global Continues International Expansion in Perth and Brisbane, Australia 2BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2
... , AMES, Iowa , ... technology company, announced that it will embark a $5.3 million ... $44 million DOE Investment for Advanced Biofuels Research and ... Advanced Biofuels and Bioproducts (NAABB).  Catilin and its partner, Iowa ...
... 2008 08/07 2009 ... MEUR %Sales Var.% MEUR %Sales Var.%, Southern Europe (1) 36.4 ... 11.3 23 17 13.1 23 16, ... 1.5 3 (25), SLIT ...
... , , ... AB (publ),and BioChromix AB announced today the formation of BioChromix Pharma ... its unique,knowledge of molecular chemistry. Karolinska Development will initially take,28 percent ... are very excited about BioChromix Pharma as they have a novel,approach ...
Cached Biology Technology:Catilin Contributes Key Extraction, Sequestration and Conversion Technologies to NAABB Consortium Developing Algal Biofuels 2Catilin Contributes Key Extraction, Sequestration and Conversion Technologies to NAABB Consortium Developing Algal Biofuels 3STALLERGENES : Sales Guidance Exceeded : EUR193 Million, up 13% 2STALLERGENES : Sales Guidance Exceeded : EUR193 Million, up 13% 3Karolinska Development Expands its Life Science Portfolio With BioChromix Pharma 2Karolinska Development Expands its Life Science Portfolio With BioChromix Pharma 3
(Date:12/15/2014)... 12, 2014 Research and Markets ... the "Global Facial Recognition Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 Facial recognition is ... Facial recognition system measures the overall facial feature ... mouth, and the distance between eyes. Facial recognition ...
(Date:12/11/2014)... ST. PAUL, Minn. , Dec. 10, 2014 ... in wireless physiologic monitoring, has released a new ... changing needs of preclinical toxicology researchers. M series, ... to help toxicologists collect the best possible physiologic ... studies. Adding functional endpoints to toxicology ...
(Date:12/10/2014)... , Dec. 9, 2014 CIE San Diego ... that provides the connective tissue that enhances care coordination ... to easily share client-level information; earned a second $1 ... to organizations serving seniors aging in community and; will ... on December 11 th 4-6p. CIE ...
Breaking Biology News(10 mins):Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3New telemetry implants expected to change how large animal toxicology studies are conducted 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4
... changing climate there,s a good chance that forest fires in ... and according to one expert speaking today at a professional ... this region is difficult to predict, will always be variable, ... understand, however, that fire is not only inevitable but also ...
... NEW YORK (February 24, 2010) An international ... used mouse embryonic stem cells to replace diseased retinal ... retinitis pigmentosa. This strategy could potentially become a new ... that affects approximately one in 3,000 to 4,000 people, ...
... ensure that people with rare forms of cancer are not denied ... major European cancer conference to be held in Milan on 9 ... same right to receive proper treatment as all other patients", said ... at the Milan Istituto Nazionale Tumori and co-chair of the ESMO ...
Cached Biology News:More frequent fires could aid ecosystems 2More frequent fires could aid ecosystems 3Stem cells restore sight in mouse model of retinitis pigmentosa 2Stem cells restore sight in mouse model of retinitis pigmentosa 3'Rare' cancers in the spotlight at major European conference 2
X-prolyl aminopeptidase (aminopeptidase P) 1, soluble...
2,4,6, Trinitrophenyl hapten is conjugated to lipopolysaccharide (LPS)....
SHEEP ANTI BOVINE LACTOPEROXIDASE...
... the ultimate in utility and flexibility press-to-seal ... the needs of the researcher. They are ... or as sheet material that can be ... isolators are autoclavable and non-cytotoxic and can ...
Biology Products: